Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Demeetra AgBio

Main focus: Therapeutic cannabis

Company stage: IND filing

Diseases: Undisclosed

Genome editing tool: Cas-CLOVER

Funding stage: Private

Location: Lexington, KY, USA

Website: https://demeetra.com/

Partners: Poseida Therapeutics, Sanofi

Demeetra Agbio is a privately held agricultural and therapeutic gene-editing company. Based in Kentrucky, US, the company utilises its proprietary Cas-CLOVER platform to genetically modify plants for pharmaceutical use. The Cas-CLOVER system uses two guide RNAs (gRNAs) rather than the conventional single gRNA used in CRISPR-Cas9 editing. Demeetra Agbio's components are licensed to several companies including Sanofi and Poseida Therapeutics.

Tags

HashtagDemeetra AgBio

Company: Demeetra AgBio
close
Search CRISPR Medicine